Squarepoint’s Corindus Vascular Robotics CVRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-10,724
Closed -$32K – 2854
2019
Q2
$32K Sell
10,724
-3,376
-24% -$8.46K ﹤0.01% 2304
2019
Q1
$25K Sell
14,100
-15,200
-52% -$21K ﹤0.01% 2091
2018
Q4
$25K Sell
29,300
-223,600
-88% -$267K ﹤0.01% 1860
2018
Q3
$359K Buy
252,900
+150,600
+147% +$165K ﹤0.01% 1456
2018
Q2
$84K Buy
+102,300
New +$98.7K ﹤0.01% 1653

Other funds holding CVRS

Squarepoint's CVRS Position: Q3 2019 in Review

Squarepoint sold out of Corindus Vascular Robotics (CVRS) in Q3 2019, closing a stake of 10,724 shares — an estimated $32K sold.

Squarepoint first reported a position in CVRS in Q2 2018 and held it in 5 quarters. The position peaked at $359K in Q3 2018. 101 funds tracked by Wall St. Rank hold CVRS as of Q3 2019.

  • Squarepoint reported no remaining Corindus Vascular Robotics position as of Q3 2019 after selling out during the quarter.
  • Squarepoint sold 10,724 Corindus Vascular Robotics shares in Q3 2019, an estimated $32K.
  • Squarepoint first reported a position in Corindus Vascular Robotics in Q2 2018 and held it in 5 quarters.
  • Squarepoint's Corindus Vascular Robotics position peaked at $359K in Q3 2018.
  • 101 funds tracked by Wall St. Rank held Corindus Vascular Robotics as of Q3 2019.

Based on Squarepoint's 13F filing for Q3 2019, filed 14 Nov 2019.